Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ankara University
Medullary thyroid carcinoma treated with radioactive iodine therapy
June 2nd, 2006
Medullary thyroid carcinoma (MTC) could be treated with radioactive iodine therapy. "Elevated levels of basal and stimulated calcitonin are commonly seen in hereditary and sporadic MTC following total thyroidectomy. The cause of these high levels can be residual thyroid tissue, possibly with C-cell hyperplasia, and/or residual micro-MTC foci," scientists in Turkey reported. "MTC does not have the ability to concentrate radioactive iodine," explained M.F. Erdogan and colleagues, Ankara University. "However, radioactive iodine trapped by thyroid follicular cells may affect the neighbouring parafollicular cells. [The study's aim was] to investigate the...
Source: Medicine & Law Weekly (2006-06-02)
|
